Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318772 · ClinicalTrials.gov registry record
Clinical Image Evaluation for the DREX-KL80 Imaging System
A clinical trial of Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation., sponsored by Toshiba America Medical Systems.
- Completed
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT01318772: Completed study of Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation., sponsored by Toshiba America Medical Systems.
NCT01318772 is a study of Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation. that has completed, run by Toshiba America Medical Systems. The registered enrollment target is 42 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318772, a study of Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation., has completed, sponsored by Toshiba America Medical Systems.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to acquire the clinical data required by the United States Food and Drug Administration (USFDA) for 510(k) submission, for approval of a new high resolution imaging system for fluoroscopy/radiography. It is expected that the new KALARE (DREX-KL80)high resolution imaging system will meet the design specifications. A minimum of 30 cases will be submitted for evaluation of claims for intended clinical applications.
Primary Outcome
Collect 30 to 60 represenative images to support pre-market submission.
Conditions Studied
Interventions
- DEVICE Radiography and Fluoroscopy Imaging System
Study Locations (1)
Nevada
- SDMI - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-01 |
What the finished NCT01318772 record still lists
NCT01318772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 1 condition, with Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation. appearing as the primary indexed condition, and to 1 intervention - of which Radiography and Fluoroscopy Imaging System is the first listed.
NCT01318772 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT01318772 about?
NCT01318772 is a clinical study titled "Clinical Image Evaluation for the DREX-KL80 Imaging System". The purpose of this study is to acquire the clinical data required by the United States Food and Drug Administration (USFDA) for 510(k) submission, for approval of a new high resolution imaging system for fluoroscopy/radiography. It is expected that the new KALARE (DREX-KL80)high resolution imaging ...
What is the current status of trial NCT01318772?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2010-12. Estimated completion is 2011-01.
What conditions does trial NCT01318772 study?
This clinical trial studies the following conditions: Obtain Diagnostic Images With the New Digital Camera and Image Processor for Evaluation..
What interventions are being tested in trial NCT01318772?
The interventions under investigation include: Radiography and Fluoroscopy Imaging System (DEVICE).
Who is sponsoring clinical trial NCT01318772?
This trial is sponsored by Toshiba America Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01318772 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia